Correction to: BMC Med 13, 237 (2015)

https://doi.org/10.1186/s12916-015-0495-0

There was missing information in the Competing Interests section of our published article [1].

The statement authored by Zarir F. Udwadia should read as follows:

“ZUF has participated in trials for Cipla Pharmaceutical and Boehringer for Pirfenidone and Nintedanib, two of the drugs that were referred to in the article.”

1. 1.

   Richeldi L, Rubin AS, Avdeev S, Udwadia ZF, Xu ZJ. Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China. BMC Med. 2015;13:237 https://doi.org/10.1186/s12916-015-0495-0.

   Article Google Scholar

Download references

Affiliations

1. Southampton Respiratory Biomedical Research Unit, Mailpoint 813, LE75 E Level, South Academic Block, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK

   Luca Richeldi

2. Federal University of Porto Alegre (UFCSPA), Pulmonary Department of Santa Casa Hospital, Porto Alegre, Brazil

   Adalberto Sperb Rubin

3. Clinical Department, Pulmonology Research Institute, 32, 11-th Parkovaya str., Moscow, 105077, Russia

   Sergey Avdeev

4. Hinduja Hospital and Research Centre, Mahim, Mumbai, 400016, India

   Zarir F. Udwadia

5. Breach Candy Hospital, B. Desai Road, Mumbai, 400026, India

   Zarir F. Udwadia

6. Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

   Zuo Jun Xu

1. Luca RicheldiView author publications

   You can also search for this author in PubMed Google Scholar

2. Adalberto Sperb RubinView author publications

   You can also search for this author in PubMed Google Scholar

3. Sergey AvdeevView author publications

   You can also search for this author in PubMed Google Scholar

4. Zarir F. UdwadiaView author publications

   You can also search for this author in PubMed Google Scholar

5. Zuo Jun XuView author publications

   You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Richeldi.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Cite this article

Richeldi, L., Rubin, A.S., Avdeev, S. et al. Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China. BMC Med 19, 220 (2021). https://doi.org/10.1186/s12916-021-02111-4

Download citation

• Published: 05 September 2021

• DOI: https://doi.org/10.1186/s12916-021-02111-4